ClinicalTrials.govpublic full text
The Effect of Rivaroxaban in Sickle Cell Disease
sickle cell anemia, sickle cell-beta0-thalassemia, sickle cell disease, rivaroxaban, direct xa inhibition, coagulation, anticoagulation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831687
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.